Page last updated: 2024-08-21

quinazolines and enalapril

quinazolines has been researched along with enalapril in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, T; Ishizaki, T; Murabayashi, S; Tomiyama, T1
Baba, T; Takebe, K; Tomiyama, T1
Mochizuki, Y; Oishi, M; Takasu, T1
Bartha, E; Habon, T; Halmosi, R; Hideg, K; Kálai, T; Kalman, E; Kiss, GN; Kulcsár, G; Sumegi, B; Toth, K1

Trials

2 trial(s) available for quinazolines and enalapril

ArticleYear
Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects.
    European journal of clinical pharmacology, 1992, Volume: 43, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adult; Arginine Vasopressin; Atrial Natriuretic Factor; Enalapril; Humans; Male; Premedication; Quinazolines; Renin-Angiotensin System; Sodium

1992
Enhancement by an ACE inhibitor of first-dose hypotension caused by an alpha 1-blocker.
    The New England journal of medicine, 1990, Apr-26, Volume: 322, Issue:17

    Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Cholinesterase Inhibitors; Drug Synergism; Enalapril; Humans; Quinazolines

1990

Other Studies

2 other study(ies) available for quinazolines and enalapril

ArticleYear
Effects of bunazosin hydrochloride sustained-release formulation on cerebral circulation.
    International angiology : a journal of the International Union of Angiology, 2000, Volume: 19, Issue:1

    Topics: Acetazolamide; Adrenergic alpha-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Caudate Nucleus; Cerebral Infarction; Cerebrovascular Circulation; Delayed-Action Preparations; Diuretics; Enalapril; Female; Humans; Injections, Intravenous; Male; Occipital Lobe; Parietal Lobe; Quinazolines; Tomography, X-Ray Computed

2000
Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Journal of cardiovascular pharmacology, 2008, Volume: 52, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Enalapril; Enzyme Inhibitors; Fibrosis; Heart Failure; Male; Myocardial Infarction; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling

2008